[1] Yasutake Y, Fujii Y, Nishioka T, et al. Structural evidence for enhancement of sequential vitamin D3 hydroxylation activities by directed evolution of cytochrome P450 Vitamin D3 hydroxylase[J]. American Society for Biochemistry and Molecular Biology, 2010, 385: (41) 170-175. [2] Fujii Y, Kabumoto H, Nishimura K, et al. Purification, characterization,and directed evolution study of a vitamin D3 hydroxylase from Pseudonocardia autotrophica[J]. Biochemical and Biophysical Research Communications, 2009, 385(2): 170-175. [3] Schuster I. Cytochromes P450 are essential players in the vitamin D signaling system[J]. Biochimica et Biophysica Acta, 2011, 1814 (1): 186-199. [4] Takeda K, Asou T, Mastsuda A, et al. Application of cyclodextrin to microbial transformation of vitamin D3 and 1α, 25-dihydroxyvitamin D3[J]. Ferment, Bioeng, 1994, 78(5): 380-382. [5] Sakaki T, Sawada N, Takeyama K, et al. Enzymatic properties of mouse 25-hydroxyvitamin D3 1α-hydroxylase expressed in Escherichia coli[J]. Biochem, 1999, 265: 950-956. [6] Kawauchi H, Sasaki. J, Adachi T, et al. Cloning and nucleotide sequence of a bacterial cytochrome P-450VD25 gene encoding vitamin D3 25-hydroxylase[J]. Biochim Biophys, 1994, 1219: 179-183. [7] Sakaki T, Shibata AM, Yabusaki Y, et al. Organella-targeted expression of rat liver cytochrome P450c27 in yeast. Genetically engineered alteration of mitochondrial P450 into a microsomal form creates a novel functional electron transport chain[J]. Biol Chem,1992, 267: 16497-16502. [8] Yamasaki T, Izumi S, Ide H, et al. Identification of a novel rat microsomal vitamin D3 25-hydroxylase[J]. Biol Chem, 2004,279: 22848-22856. [9] Sakaki T, Sugimoto H, Hayashi K, et al. Bioconversion of vitamin D to its active form by bacterial or manmmalian cytochrome P450[J]. Biochim Biophys Acta, 2011, 1814(1): 249-256. [10] Imoto N, Nishioka T, Tamura T, et al. Permeabilization induced by lipid II-targeting lantibiotic nisin and its effect on the bioconversion of vitamin D3 to 25-hydroxyxitamin D3 by Rhodococcus erythropolis [J]. Biochemical and Biophysical Research Communications,2011, 405: 393-398. [11] Sawada N, Sakaki T, kitanaka S, et al. Enzymatic properties of human 25-hydroxyvitamin D3 1alpha-hydroxylase coexpression with adrenodoxin and NADPH-adrenodoxin reuctase in Escherichia coli[J]. Bochem, 1999, 265: 950-956. [12] Strushkevish N, Usanov SA, Plotnikov AN, et al. Structural analysis of CYP2R1 in complex with vitamin D3[J]. J Mol Biol, 2008,380(1): 95-105. [13] Uchidaa E, Kagawab N, Sakaki T, et al. Purification and characterization of mouse CYP 27B1 overproduced by an E.coli system coexpressing molecular chaperonins GroEL/ES[J]. Biochemical and Biophysical Research Communications, 2004, 323(2): 505-511. [14] Fujii Y, Norhisa K, Fujii T, et al. Construction of a novel expression vector on Pseudonocardia autotrophia and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor[J]. Bichemical and Biophysical Research Communications, 2011, 404: 511-516. [15] Yasutake Y, Tamura T. Efficient production of active form of vitamin D3 by microbial conversion. Synthesiology, 2011, 4(4) [J] : 227-235. [16] Taek SJ, Lauchli R, Arnold FH. Cytochrome P450: taming a wild type enzyme[J].Current Opinion in Biotechnology, 2011, 22: 809-817. [17] Sasaki J, Miyazaki A, Saito M, et al. Transformation of vitamin D3 to 1alpha, 25-dyhydroxyvitmin D3 via 25-hydroxyvitamin D3 using Amycolata sp.strains[J]. Microbiol Biotechol, 1998, 1219(2): 179-183. [18] Sasaki J, Mikami A, Mizoue K, et al. Transformation of 25-and 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 by using Streptomyces sp.Strains[J]. Environ Microbiol, 1991, 57 (10): 2841-2846. [19] Hayashi K, Yasuda K, Sugimoto H, et al. Three-step hydroxylation of vitamin D3 by a genetically engineered CYP105A1[J] FEBS J,2010, 277(19): 1742-4658. [20] Omer CA, Lenstra R, Litle PJ, et al. Genes for two herbicideinducible cytomchromes P-450 from Streptomyces groseolus[J].Bacteriol, 1990, 172(6): 3335-3345. [21] Sawada N, Sakaki T, Yoneda S, et al. Conversion of vitamin D3 to 1α, 25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1[J]. Biochemical and Biophysical Resrarch Communications,2004, 320: 156-164. [22] Seifert A, Vomund S, Grohmann K, et al. Rational design of a minimal and highly enriched CYP102A1 mutant library with improved region-, stereo- and chemoselectivity[J]. Chembiochem, 2009,10(5): 853-861. [23] Weber E, Seifert A, Antonovici M, et al. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes[J]. Chembiochem, 2010, 11(3): 2502-2505. [24] Liu W, Hansen JN. Some chemical and physical properties of nisn,a small protein antibiotic produced by Lactococcus lactis[J].Environ Microbiol, 1990, 56: 2551-2558. |